ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,731Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 559

$444K Total Retail Price of All Prescriptions

Rank: 48 out of 559

429 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 429 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 429 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,971 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
HYDROCODONE-ACETAMINOPHEN 378 361 S3 1 7
LEVOTHYROXINE SODIUM 346 295 2 2
SIMVASTATIN 331 311 3 3
LISINOPRIL 282 275 4 1
AMLODIPINE BESYLATE 231 219 5 6
OMEPRAZOLE 222 193 6 4
FUROSEMIDE 198 175 7 11
CITALOPRAM HBR 193 184 8 21
NAMENDA 184 184 9 56
ZOLPIDEM TARTRATE 160 122 10 17
WARFARIN SODIUM 142 137 11 24
POTASSIUM CHLORIDE 129 129 12 23
ATORVASTATIN CALCIUM 119 100 13 20
METOPROLOL TARTRATE 116 115 14 12
DONEPEZIL HCL 114 114 15 36
AZITHROMYCIN 108 88 16 39
GABAPENTIN 103 85 17 9
HYDROCHLOROTHIAZIDE 102 95 18 8
METOPROLOL SUCCINATE 93 89 19 16
METFORMIN HCL 92 85 20 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 85 79 21 18
TAMSULOSIN HCL 76 62 22 25
LOSARTAN POTASSIUM 73 63 23 14
ATENOLOL 71 71 24 15
PHENYTOIN SODIUM EXTENDED 65 52 25 123
GLIPIZIDE 61 61 26 31
TRAZODONE HCL 61 60 26 28
FLUTICASONE PROPIONATE 60 50 28 22
CLOPIDOGREL 56 51 29 51
SERTRALINE HCL 56 42 29 19
TRIAMTERENE-HCTZ 55 43 31 47
ALENDRONATE SODIUM 53 23 32 13
ALLOPURINOL 52 50 33 34
METHYLPREDNISOLONE 50 48 34 173
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 3, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.